nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN5A—purkinje fiber—coronary artery disease	0.114	0.431	CbGeAlD
Mepivacaine—SCN5A—endocardium—coronary artery disease	0.0589	0.222	CbGeAlD
Mepivacaine—SCN5A—sinoatrial node—coronary artery disease	0.0559	0.21	CbGeAlD
Mepivacaine—SCN5A—cardiac ventricle—coronary artery disease	0.00496	0.0187	CbGeAlD
Mepivacaine—SCN5A—myocardium—coronary artery disease	0.00467	0.0176	CbGeAlD
Mepivacaine—SCN4A—heart—coronary artery disease	0.0042	0.0158	CbGeAlD
Mepivacaine—SCN3A—heart—coronary artery disease	0.00327	0.0123	CbGeAlD
Mepivacaine—SCN5A—heart—coronary artery disease	0.00326	0.0123	CbGeAlD
Mepivacaine—SCN5A—cardiovascular system—coronary artery disease	0.00307	0.0116	CbGeAlD
Mepivacaine—SCN5A—cardiac atrium—coronary artery disease	0.00279	0.0105	CbGeAlD
Mepivacaine—SCN2A—blood—coronary artery disease	0.00277	0.0104	CbGeAlD
Mepivacaine—SCN10A—blood—coronary artery disease	0.00267	0.0101	CbGeAlD
Mepivacaine—SCN3A—blood—coronary artery disease	0.00244	0.00917	CbGeAlD
Mepivacaine—SCN5A—blood—coronary artery disease	0.00243	0.00915	CbGeAlD
Mepivacaine—Shock—Perindopril—coronary artery disease	0.000677	0.00126	CcSEcCtD
Mepivacaine—Tachycardia—Perindopril—coronary artery disease	0.000672	0.00125	CcSEcCtD
Mepivacaine—Urticaria—Simvastatin—coronary artery disease	0.000672	0.00125	CcSEcCtD
Mepivacaine—Anxiety—Losartan—coronary artery disease	0.000671	0.00125	CcSEcCtD
Mepivacaine—Hypersensitivity—Clopidogrel—coronary artery disease	0.000671	0.00125	CcSEcCtD
Mepivacaine—Anaphylactic shock—Furosemide—coronary artery disease	0.000669	0.00125	CcSEcCtD
Mepivacaine—Body temperature increased—Simvastatin—coronary artery disease	0.000669	0.00125	CcSEcCtD
Mepivacaine—Headache—Rosuvastatin—coronary artery disease	0.000668	0.00125	CcSEcCtD
Mepivacaine—Paraesthesia—Trandolapril—coronary artery disease	0.000667	0.00124	CcSEcCtD
Mepivacaine—Hypersensitivity—Lovastatin—coronary artery disease	0.000666	0.00124	CcSEcCtD
Mepivacaine—Tension—Ramipril—coronary artery disease	0.000666	0.00124	CcSEcCtD
Mepivacaine—Hyperhidrosis—Perindopril—coronary artery disease	0.000666	0.00124	CcSEcCtD
Mepivacaine—Asthenia—Fenofibrate—coronary artery disease	0.000664	0.00124	CcSEcCtD
Mepivacaine—Paraesthesia—Enalapril—coronary artery disease	0.000664	0.00124	CcSEcCtD
Mepivacaine—Erythema—Timolol—coronary artery disease	0.000663	0.00124	CcSEcCtD
Mepivacaine—Hypotension—Captopril—coronary artery disease	0.000663	0.00124	CcSEcCtD
Mepivacaine—Somnolence—Trandolapril—coronary artery disease	0.00066	0.00123	CcSEcCtD
Mepivacaine—Tinnitus—Lisinopril—coronary artery disease	0.000659	0.00123	CcSEcCtD
Mepivacaine—Nervousness—Ramipril—coronary artery disease	0.000659	0.00123	CcSEcCtD
Mepivacaine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000659	0.00123	CcSEcCtD
Mepivacaine—Shock—Furosemide—coronary artery disease	0.000659	0.00123	CcSEcCtD
Mepivacaine—Somnolence—Enalapril—coronary artery disease	0.000657	0.00123	CcSEcCtD
Mepivacaine—Pruritus—Fenofibrate—coronary artery disease	0.000655	0.00122	CcSEcCtD
Mepivacaine—Paraesthesia—Telmisartan—coronary artery disease	0.000655	0.00122	CcSEcCtD
Mepivacaine—Hypersensitivity—Ezetimibe—coronary artery disease	0.000653	0.00122	CcSEcCtD
Mepivacaine—Asthenia—Clopidogrel—coronary artery disease	0.000653	0.00122	CcSEcCtD
Mepivacaine—Tension—Timolol—coronary artery disease	0.000651	0.00121	CcSEcCtD
Mepivacaine—Asthenia—Lovastatin—coronary artery disease	0.000649	0.00121	CcSEcCtD
Mepivacaine—Somnolence—Telmisartan—coronary artery disease	0.000648	0.00121	CcSEcCtD
Mepivacaine—Hyperhidrosis—Furosemide—coronary artery disease	0.000647	0.00121	CcSEcCtD
Mepivacaine—Oedema—Losartan—coronary artery disease	0.000646	0.0012	CcSEcCtD
Mepivacaine—Anaphylactic shock—Losartan—coronary artery disease	0.000646	0.0012	CcSEcCtD
Mepivacaine—Nervousness—Timolol—coronary artery disease	0.000644	0.0012	CcSEcCtD
Mepivacaine—Pruritus—Clopidogrel—coronary artery disease	0.000644	0.0012	CcSEcCtD
Mepivacaine—Hypotension—Perindopril—coronary artery disease	0.000643	0.0012	CcSEcCtD
Mepivacaine—Pruritus—Lovastatin—coronary artery disease	0.00064	0.00119	CcSEcCtD
Mepivacaine—Paraesthesia—Captopril—coronary artery disease	0.000637	0.00119	CcSEcCtD
Mepivacaine—Asthenia—Ezetimibe—coronary artery disease	0.000636	0.00119	CcSEcCtD
Mepivacaine—Tremor—Ramipril—coronary artery disease	0.000636	0.00119	CcSEcCtD
Mepivacaine—Shock—Losartan—coronary artery disease	0.000635	0.00119	CcSEcCtD
Mepivacaine—Urticaria—Valsartan—coronary artery disease	0.000634	0.00118	CcSEcCtD
Mepivacaine—Chills—Lisinopril—coronary artery disease	0.000634	0.00118	CcSEcCtD
Mepivacaine—Nausea—Rosuvastatin—coronary artery disease	0.000634	0.00118	CcSEcCtD
Mepivacaine—Urticaria—Olmesartan—coronary artery disease	0.000631	0.00118	CcSEcCtD
Mepivacaine—Somnolence—Captopril—coronary artery disease	0.000631	0.00118	CcSEcCtD
Mepivacaine—Tachycardia—Losartan—coronary artery disease	0.00063	0.00118	CcSEcCtD
Mepivacaine—Body temperature increased—Olmesartan—coronary artery disease	0.000628	0.00117	CcSEcCtD
Mepivacaine—Pruritus—Ezetimibe—coronary artery disease	0.000627	0.00117	CcSEcCtD
Mepivacaine—Hypotension—Furosemide—coronary artery disease	0.000626	0.00117	CcSEcCtD
Mepivacaine—Vision blurred—Timolol—coronary artery disease	0.000625	0.00117	CcSEcCtD
Mepivacaine—Hyperhidrosis—Losartan—coronary artery disease	0.000624	0.00116	CcSEcCtD
Mepivacaine—Agitation—Ramipril—coronary artery disease	0.000624	0.00116	CcSEcCtD
Mepivacaine—Hypersensitivity—Simvastatin—coronary artery disease	0.000623	0.00116	CcSEcCtD
Mepivacaine—Asthenia—Eplerenone—coronary artery disease	0.000623	0.00116	CcSEcCtD
Mepivacaine—Angioedema—Ramipril—coronary artery disease	0.00062	0.00116	CcSEcCtD
Mepivacaine—Paraesthesia—Perindopril—coronary artery disease	0.000618	0.00115	CcSEcCtD
Mepivacaine—Urticaria—Niacin—coronary artery disease	0.000617	0.00115	CcSEcCtD
Mepivacaine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000616	0.00115	CcSEcCtD
Mepivacaine—Erythema—Lisinopril—coronary artery disease	0.000615	0.00115	CcSEcCtD
Mepivacaine—Pruritus—Eplerenone—coronary artery disease	0.000614	0.00115	CcSEcCtD
Mepivacaine—Body temperature increased—Niacin—coronary artery disease	0.000614	0.00114	CcSEcCtD
Mepivacaine—Dizziness—Fenofibrate—coronary artery disease	0.000612	0.00114	CcSEcCtD
Mepivacaine—Somnolence—Perindopril—coronary artery disease	0.000612	0.00114	CcSEcCtD
Mepivacaine—Syncope—Ramipril—coronary artery disease	0.000609	0.00113	CcSEcCtD
Mepivacaine—Urticaria—Pravastatin—coronary artery disease	0.000607	0.00113	CcSEcCtD
Mepivacaine—Asthenia—Simvastatin—coronary artery disease	0.000607	0.00113	CcSEcCtD
Mepivacaine—Angioedema—Timolol—coronary artery disease	0.000606	0.00113	CcSEcCtD
Mepivacaine—Body temperature increased—Pravastatin—coronary artery disease	0.000604	0.00113	CcSEcCtD
Mepivacaine—Tension—Lisinopril—coronary artery disease	0.000604	0.00113	CcSEcCtD
Mepivacaine—Hypotension—Losartan—coronary artery disease	0.000604	0.00113	CcSEcCtD
Mepivacaine—Dizziness—Clopidogrel—coronary artery disease	0.000602	0.00112	CcSEcCtD
Mepivacaine—Paraesthesia—Furosemide—coronary artery disease	0.000601	0.00112	CcSEcCtD
Mepivacaine—Pruritus—Simvastatin—coronary artery disease	0.000598	0.00112	CcSEcCtD
Mepivacaine—Dizziness—Lovastatin—coronary artery disease	0.000598	0.00111	CcSEcCtD
Mepivacaine—Nervousness—Lisinopril—coronary artery disease	0.000598	0.00111	CcSEcCtD
Mepivacaine—Loss of consciousness—Ramipril—coronary artery disease	0.000596	0.00111	CcSEcCtD
Mepivacaine—Back pain—Lisinopril—coronary artery disease	0.000595	0.00111	CcSEcCtD
Mepivacaine—Somnolence—Furosemide—coronary artery disease	0.000595	0.00111	CcSEcCtD
Mepivacaine—Syncope—Timolol—coronary artery disease	0.000595	0.00111	CcSEcCtD
Mepivacaine—Urticaria—Trandolapril—coronary artery disease	0.00059	0.0011	CcSEcCtD
Mepivacaine—Vomiting—Fenofibrate—coronary artery disease	0.000589	0.0011	CcSEcCtD
Mepivacaine—Hypersensitivity—Valsartan—coronary artery disease	0.000588	0.0011	CcSEcCtD
Mepivacaine—Convulsion—Ramipril—coronary artery disease	0.000588	0.0011	CcSEcCtD
Mepivacaine—Urticaria—Enalapril—coronary artery disease	0.000587	0.0011	CcSEcCtD
Mepivacaine—Body temperature increased—Trandolapril—coronary artery disease	0.000587	0.00109	CcSEcCtD
Mepivacaine—Dizziness—Ezetimibe—coronary artery disease	0.000586	0.00109	CcSEcCtD
Mepivacaine—Body temperature increased—Enalapril—coronary artery disease	0.000585	0.00109	CcSEcCtD
Mepivacaine—Loss of consciousness—Timolol—coronary artery disease	0.000583	0.00109	CcSEcCtD
Mepivacaine—Headache—Fenofibrate—coronary artery disease	0.00058	0.00108	CcSEcCtD
Mepivacaine—Vision blurred—Lisinopril—coronary artery disease	0.00058	0.00108	CcSEcCtD
Mepivacaine—Paraesthesia—Losartan—coronary artery disease	0.00058	0.00108	CcSEcCtD
Mepivacaine—Urticaria—Telmisartan—coronary artery disease	0.000579	0.00108	CcSEcCtD
Mepivacaine—Vomiting—Clopidogrel—coronary artery disease	0.000579	0.00108	CcSEcCtD
Mepivacaine—Tremor—Lisinopril—coronary artery disease	0.000577	0.00108	CcSEcCtD
Mepivacaine—Body temperature increased—Telmisartan—coronary artery disease	0.000577	0.00108	CcSEcCtD
Mepivacaine—Anxiety—Ramipril—coronary artery disease	0.000576	0.00107	CcSEcCtD
Mepivacaine—Vomiting—Lovastatin—coronary artery disease	0.000575	0.00107	CcSEcCtD
Mepivacaine—Somnolence—Losartan—coronary artery disease	0.000574	0.00107	CcSEcCtD
Mepivacaine—Dizziness—Eplerenone—coronary artery disease	0.000574	0.00107	CcSEcCtD
Mepivacaine—Asthenia—Valsartan—coronary artery disease	0.000573	0.00107	CcSEcCtD
Mepivacaine—Hypertension—Timolol—coronary artery disease	0.000573	0.00107	CcSEcCtD
Mepivacaine—Hypersensitivity—Niacin—coronary artery disease	0.000572	0.00107	CcSEcCtD
Mepivacaine—Asthenia—Olmesartan—coronary artery disease	0.00057	0.00106	CcSEcCtD
Mepivacaine—Headache—Clopidogrel—coronary artery disease	0.00057	0.00106	CcSEcCtD
Mepivacaine—Headache—Lovastatin—coronary artery disease	0.000566	0.00106	CcSEcCtD
Mepivacaine—Pruritus—Valsartan—coronary artery disease	0.000565	0.00105	CcSEcCtD
Mepivacaine—Vomiting—Ezetimibe—coronary artery disease	0.000564	0.00105	CcSEcCtD
Mepivacaine—Hypersensitivity—Pravastatin—coronary artery disease	0.000563	0.00105	CcSEcCtD
Mepivacaine—Anxiety—Timolol—coronary artery disease	0.000563	0.00105	CcSEcCtD
Mepivacaine—Angioedema—Lisinopril—coronary artery disease	0.000562	0.00105	CcSEcCtD
Mepivacaine—Pruritus—Olmesartan—coronary artery disease	0.000562	0.00105	CcSEcCtD
Mepivacaine—Body temperature increased—Captopril—coronary artery disease	0.000561	0.00105	CcSEcCtD
Mepivacaine—Dizziness—Simvastatin—coronary artery disease	0.000559	0.00104	CcSEcCtD
Mepivacaine—Bupivacaine—CYP2C19—coronary artery disease	0.000559	0.704	CrCbGaD
Mepivacaine—Asthenia—Niacin—coronary artery disease	0.000557	0.00104	CcSEcCtD
Mepivacaine—Headache—Ezetimibe—coronary artery disease	0.000556	0.00104	CcSEcCtD
Mepivacaine—Anaphylactic shock—Ramipril—coronary artery disease	0.000554	0.00103	CcSEcCtD
Mepivacaine—Oedema—Ramipril—coronary artery disease	0.000554	0.00103	CcSEcCtD
Mepivacaine—Syncope—Lisinopril—coronary artery disease	0.000552	0.00103	CcSEcCtD
Mepivacaine—Vomiting—Eplerenone—coronary artery disease	0.000552	0.00103	CcSEcCtD
Mepivacaine—Nausea—Fenofibrate—coronary artery disease	0.00055	0.00103	CcSEcCtD
Mepivacaine—Pruritus—Niacin—coronary artery disease	0.000549	0.00102	CcSEcCtD
Mepivacaine—Asthenia—Pravastatin—coronary artery disease	0.000549	0.00102	CcSEcCtD
Mepivacaine—Urticaria—Perindopril—coronary artery disease	0.000547	0.00102	CcSEcCtD
Mepivacaine—Hypersensitivity—Trandolapril—coronary artery disease	0.000547	0.00102	CcSEcCtD
Mepivacaine—Shock—Ramipril—coronary artery disease	0.000545	0.00102	CcSEcCtD
Mepivacaine—Hypersensitivity—Enalapril—coronary artery disease	0.000545	0.00102	CcSEcCtD
Mepivacaine—Body temperature increased—Perindopril—coronary artery disease	0.000544	0.00102	CcSEcCtD
Mepivacaine—Headache—Eplerenone—coronary artery disease	0.000544	0.00101	CcSEcCtD
Mepivacaine—Oedema—Timolol—coronary artery disease	0.000541	0.00101	CcSEcCtD
Mepivacaine—Anaphylactic shock—Timolol—coronary artery disease	0.000541	0.00101	CcSEcCtD
Mepivacaine—Pruritus—Pravastatin—coronary artery disease	0.000541	0.00101	CcSEcCtD
Mepivacaine—Loss of consciousness—Lisinopril—coronary artery disease	0.000541	0.00101	CcSEcCtD
Mepivacaine—Nausea—Clopidogrel—coronary artery disease	0.000541	0.00101	CcSEcCtD
Mepivacaine—Tachycardia—Ramipril—coronary artery disease	0.000541	0.00101	CcSEcCtD
Mepivacaine—Vomiting—Simvastatin—coronary artery disease	0.000538	0.001	CcSEcCtD
Mepivacaine—Hypersensitivity—Telmisartan—coronary artery disease	0.000537	0.001	CcSEcCtD
Mepivacaine—Nausea—Lovastatin—coronary artery disease	0.000537	0.001	CcSEcCtD
Mepivacaine—Hyperhidrosis—Ramipril—coronary artery disease	0.000535	0.000998	CcSEcCtD
Mepivacaine—Asthenia—Trandolapril—coronary artery disease	0.000533	0.000993	CcSEcCtD
Mepivacaine—Shock—Timolol—coronary artery disease	0.000533	0.000993	CcSEcCtD
Mepivacaine—Urticaria—Furosemide—coronary artery disease	0.000532	0.000992	CcSEcCtD
Mepivacaine—Asthenia—Enalapril—coronary artery disease	0.000531	0.000989	CcSEcCtD
Mepivacaine—Headache—Simvastatin—coronary artery disease	0.00053	0.000988	CcSEcCtD
Mepivacaine—Body temperature increased—Furosemide—coronary artery disease	0.000529	0.000987	CcSEcCtD
Mepivacaine—Dizziness—Valsartan—coronary artery disease	0.000528	0.000985	CcSEcCtD
Mepivacaine—Nausea—Ezetimibe—coronary artery disease	0.000527	0.000982	CcSEcCtD
Mepivacaine—Dizziness—Olmesartan—coronary artery disease	0.000526	0.00098	CcSEcCtD
Mepivacaine—Pruritus—Trandolapril—coronary artery disease	0.000525	0.00098	CcSEcCtD
Mepivacaine—Hyperhidrosis—Timolol—coronary artery disease	0.000523	0.000976	CcSEcCtD
Mepivacaine—Asthenia—Telmisartan—coronary artery disease	0.000523	0.000976	CcSEcCtD
Mepivacaine—Pruritus—Enalapril—coronary artery disease	0.000523	0.000976	CcSEcCtD
Mepivacaine—Anxiety—Lisinopril—coronary artery disease	0.000522	0.000974	CcSEcCtD
Mepivacaine—Hypotension—Ramipril—coronary artery disease	0.000518	0.000965	CcSEcCtD
Mepivacaine—Pruritus—Telmisartan—coronary artery disease	0.000516	0.000962	CcSEcCtD
Mepivacaine—Nausea—Eplerenone—coronary artery disease	0.000516	0.000961	CcSEcCtD
Mepivacaine—Dizziness—Niacin—coronary artery disease	0.000513	0.000958	CcSEcCtD
Mepivacaine—Urticaria—Losartan—coronary artery disease	0.000513	0.000957	CcSEcCtD
Mepivacaine—Body temperature increased—Losartan—coronary artery disease	0.000511	0.000952	CcSEcCtD
Mepivacaine—Asthenia—Captopril—coronary artery disease	0.000509	0.000949	CcSEcCtD
Mepivacaine—Vomiting—Valsartan—coronary artery disease	0.000508	0.000947	CcSEcCtD
Mepivacaine—Hypotension—Timolol—coronary artery disease	0.000506	0.000943	CcSEcCtD
Mepivacaine—Dizziness—Pravastatin—coronary artery disease	0.000506	0.000943	CcSEcCtD
Mepivacaine—Vomiting—Olmesartan—coronary artery disease	0.000505	0.000942	CcSEcCtD
Mepivacaine—Nausea—Simvastatin—coronary artery disease	0.000502	0.000937	CcSEcCtD
Mepivacaine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000502	0.000937	CcSEcCtD
Mepivacaine—Oedema—Lisinopril—coronary artery disease	0.000502	0.000937	CcSEcCtD
Mepivacaine—Pruritus—Captopril—coronary artery disease	0.000502	0.000936	CcSEcCtD
Mepivacaine—Headache—Valsartan—coronary artery disease	0.0005	0.000933	CcSEcCtD
Mepivacaine—Headache—Olmesartan—coronary artery disease	0.000498	0.000929	CcSEcCtD
Mepivacaine—Paraesthesia—Ramipril—coronary artery disease	0.000497	0.000927	CcSEcCtD
Mepivacaine—Shock—Lisinopril—coronary artery disease	0.000494	0.000922	CcSEcCtD
Mepivacaine—Asthenia—Perindopril—coronary artery disease	0.000494	0.000921	CcSEcCtD
Mepivacaine—Vomiting—Niacin—coronary artery disease	0.000494	0.000921	CcSEcCtD
Mepivacaine—Hypersensitivity—Furosemide—coronary artery disease	0.000493	0.00092	CcSEcCtD
Mepivacaine—Somnolence—Ramipril—coronary artery disease	0.000492	0.000918	CcSEcCtD
Mepivacaine—Dizziness—Trandolapril—coronary artery disease	0.000491	0.000916	CcSEcCtD
Mepivacaine—Tachycardia—Lisinopril—coronary artery disease	0.00049	0.000914	CcSEcCtD
Mepivacaine—Dizziness—Enalapril—coronary artery disease	0.000489	0.000912	CcSEcCtD
Mepivacaine—Pruritus—Perindopril—coronary artery disease	0.000487	0.000909	CcSEcCtD
Mepivacaine—Headache—Niacin—coronary artery disease	0.000486	0.000907	CcSEcCtD
Mepivacaine—Paraesthesia—Timolol—coronary artery disease	0.000486	0.000907	CcSEcCtD
Mepivacaine—Vomiting—Pravastatin—coronary artery disease	0.000486	0.000907	CcSEcCtD
Mepivacaine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000486	0.000905	CcSEcCtD
Mepivacaine—Dizziness—Telmisartan—coronary artery disease	0.000482	0.000899	CcSEcCtD
Mepivacaine—Somnolence—Timolol—coronary artery disease	0.000481	0.000898	CcSEcCtD
Mepivacaine—Asthenia—Furosemide—coronary artery disease	0.00048	0.000896	CcSEcCtD
Mepivacaine—Headache—Pravastatin—coronary artery disease	0.000479	0.000893	CcSEcCtD
Mepivacaine—Hypersensitivity—Losartan—coronary artery disease	0.000476	0.000887	CcSEcCtD
Mepivacaine—Nausea—Valsartan—coronary artery disease	0.000474	0.000885	CcSEcCtD
Mepivacaine—Pruritus—Furosemide—coronary artery disease	0.000474	0.000883	CcSEcCtD
Mepivacaine—Nausea—Olmesartan—coronary artery disease	0.000472	0.00088	CcSEcCtD
Mepivacaine—Vomiting—Trandolapril—coronary artery disease	0.000472	0.00088	CcSEcCtD
Mepivacaine—Vomiting—Enalapril—coronary artery disease	0.00047	0.000877	CcSEcCtD
Mepivacaine—Hypotension—Lisinopril—coronary artery disease	0.000469	0.000875	CcSEcCtD
Mepivacaine—Dizziness—Captopril—coronary artery disease	0.000469	0.000875	CcSEcCtD
Mepivacaine—Headache—Trandolapril—coronary artery disease	0.000465	0.000867	CcSEcCtD
Mepivacaine—Vomiting—Telmisartan—coronary artery disease	0.000464	0.000865	CcSEcCtD
Mepivacaine—Asthenia—Losartan—coronary artery disease	0.000463	0.000864	CcSEcCtD
Mepivacaine—Headache—Enalapril—coronary artery disease	0.000463	0.000864	CcSEcCtD
Mepivacaine—Nausea—Niacin—coronary artery disease	0.000461	0.00086	CcSEcCtD
Mepivacaine—Pruritus—Losartan—coronary artery disease	0.000457	0.000852	CcSEcCtD
Mepivacaine—Headache—Telmisartan—coronary artery disease	0.000457	0.000852	CcSEcCtD
Mepivacaine—Dizziness—Perindopril—coronary artery disease	0.000455	0.000849	CcSEcCtD
Mepivacaine—Nausea—Pravastatin—coronary artery disease	0.000454	0.000847	CcSEcCtD
Mepivacaine—Paraesthesia—Lisinopril—coronary artery disease	0.000451	0.000841	CcSEcCtD
Mepivacaine—Vomiting—Captopril—coronary artery disease	0.000451	0.000841	CcSEcCtD
Mepivacaine—Somnolence—Lisinopril—coronary artery disease	0.000447	0.000833	CcSEcCtD
Mepivacaine—Headache—Captopril—coronary artery disease	0.000444	0.000829	CcSEcCtD
Mepivacaine—Dizziness—Furosemide—coronary artery disease	0.000443	0.000826	CcSEcCtD
Mepivacaine—Nausea—Trandolapril—coronary artery disease	0.000441	0.000822	CcSEcCtD
Mepivacaine—Urticaria—Ramipril—coronary artery disease	0.00044	0.00082	CcSEcCtD
Mepivacaine—Nausea—Enalapril—coronary artery disease	0.000439	0.000819	CcSEcCtD
Mepivacaine—Vomiting—Perindopril—coronary artery disease	0.000438	0.000816	CcSEcCtD
Mepivacaine—Body temperature increased—Ramipril—coronary artery disease	0.000438	0.000816	CcSEcCtD
Mepivacaine—Nausea—Telmisartan—coronary artery disease	0.000433	0.000808	CcSEcCtD
Mepivacaine—Headache—Perindopril—coronary artery disease	0.000431	0.000804	CcSEcCtD
Mepivacaine—Urticaria—Timolol—coronary artery disease	0.00043	0.000802	CcSEcCtD
Mepivacaine—Body temperature increased—Timolol—coronary artery disease	0.000428	0.000798	CcSEcCtD
Mepivacaine—Dizziness—Losartan—coronary artery disease	0.000427	0.000797	CcSEcCtD
Mepivacaine—Vomiting—Furosemide—coronary artery disease	0.000426	0.000794	CcSEcCtD
Mepivacaine—Nausea—Captopril—coronary artery disease	0.000421	0.000786	CcSEcCtD
Mepivacaine—Headache—Furosemide—coronary artery disease	0.000419	0.000782	CcSEcCtD
Mepivacaine—Vomiting—Losartan—coronary artery disease	0.000411	0.000766	CcSEcCtD
Mepivacaine—Nausea—Perindopril—coronary artery disease	0.000409	0.000763	CcSEcCtD
Mepivacaine—Hypersensitivity—Ramipril—coronary artery disease	0.000408	0.000761	CcSEcCtD
Mepivacaine—Headache—Losartan—coronary artery disease	0.000405	0.000755	CcSEcCtD
Mepivacaine—Urticaria—Lisinopril—coronary artery disease	0.000399	0.000744	CcSEcCtD
Mepivacaine—Hypersensitivity—Timolol—coronary artery disease	0.000399	0.000744	CcSEcCtD
Mepivacaine—Nausea—Furosemide—coronary artery disease	0.000398	0.000742	CcSEcCtD
Mepivacaine—Asthenia—Ramipril—coronary artery disease	0.000397	0.000741	CcSEcCtD
Mepivacaine—Body temperature increased—Lisinopril—coronary artery disease	0.000397	0.00074	CcSEcCtD
Mepivacaine—Pruritus—Ramipril—coronary artery disease	0.000392	0.000731	CcSEcCtD
Mepivacaine—Asthenia—Timolol—coronary artery disease	0.000388	0.000724	CcSEcCtD
Mepivacaine—Nausea—Losartan—coronary artery disease	0.000384	0.000715	CcSEcCtD
Mepivacaine—Pruritus—Timolol—coronary artery disease	0.000383	0.000714	CcSEcCtD
Mepivacaine—Hypersensitivity—Lisinopril—coronary artery disease	0.00037	0.00069	CcSEcCtD
Mepivacaine—Dizziness—Ramipril—coronary artery disease	0.000366	0.000683	CcSEcCtD
Mepivacaine—Asthenia—Lisinopril—coronary artery disease	0.00036	0.000672	CcSEcCtD
Mepivacaine—Dizziness—Timolol—coronary artery disease	0.000358	0.000668	CcSEcCtD
Mepivacaine—Pruritus—Lisinopril—coronary artery disease	0.000355	0.000663	CcSEcCtD
Mepivacaine—Vomiting—Ramipril—coronary artery disease	0.000352	0.000657	CcSEcCtD
Mepivacaine—Headache—Ramipril—coronary artery disease	0.000347	0.000647	CcSEcCtD
Mepivacaine—Vomiting—Timolol—coronary artery disease	0.000344	0.000642	CcSEcCtD
Mepivacaine—Headache—Timolol—coronary artery disease	0.000339	0.000633	CcSEcCtD
Mepivacaine—Dizziness—Lisinopril—coronary artery disease	0.000332	0.000619	CcSEcCtD
Mepivacaine—Nausea—Ramipril—coronary artery disease	0.000329	0.000613	CcSEcCtD
Mepivacaine—Nausea—Timolol—coronary artery disease	0.000322	0.0006	CcSEcCtD
Mepivacaine—Vomiting—Lisinopril—coronary artery disease	0.000319	0.000596	CcSEcCtD
Mepivacaine—Headache—Lisinopril—coronary artery disease	0.000315	0.000587	CcSEcCtD
Mepivacaine—Nausea—Lisinopril—coronary artery disease	0.000298	0.000556	CcSEcCtD
Mepivacaine—Tocainide—ALB—coronary artery disease	0.000235	0.296	CrCbGaD
Mepivacaine—SCN9A—Developmental Biology—MEF2C—coronary artery disease	0.000172	0.000874	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6R—coronary artery disease	0.000171	0.000868	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6ST—coronary artery disease	0.00017	0.000862	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6ST—coronary artery disease	0.00017	0.000862	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6ST—coronary artery disease	0.000169	0.000858	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARGC1A—coronary artery disease	0.000169	0.000858	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARGC1A—coronary artery disease	0.000169	0.000858	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—GSK3B—coronary artery disease	0.000169	0.000858	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ITGB3—coronary artery disease	0.000168	0.000852	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—CREB1—coronary artery disease	0.000168	0.000851	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—LPL—coronary artery disease	0.000166	0.000843	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CD36—coronary artery disease	0.000165	0.000838	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MEF2C—coronary artery disease	0.000165	0.000836	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6R—coronary artery disease	0.000164	0.00083	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—MAPK1—coronary artery disease	0.000164	0.000829	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP2—coronary artery disease	0.000163	0.000828	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—GSK3B—coronary artery disease	0.000163	0.000824	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—GSK3B—coronary artery disease	0.000163	0.000824	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—CREB1—coronary artery disease	0.000161	0.000818	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—CREB1—coronary artery disease	0.000161	0.000818	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ITGB3—coronary artery disease	0.000161	0.000814	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—LPL—coronary artery disease	0.00016	0.00081	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—LPL—coronary artery disease	0.00016	0.00081	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MEF2C—coronary artery disease	0.000158	0.000803	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MEF2C—coronary artery disease	0.000158	0.000803	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CD36—coronary artery disease	0.000158	0.000801	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6R—coronary artery disease	0.000157	0.000798	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6R—coronary artery disease	0.000157	0.000798	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PPARG—coronary artery disease	0.000157	0.000796	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—GSK3B—coronary artery disease	0.000157	0.000795	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—GSK3B—coronary artery disease	0.000157	0.000795	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP2—coronary artery disease	0.000156	0.000792	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—GSK3B—coronary artery disease	0.000156	0.000791	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—CREB1—coronary artery disease	0.000156	0.000788	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—CREB1—coronary artery disease	0.000156	0.000788	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CREB1—coronary artery disease	0.000155	0.000785	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ITGB3—coronary artery disease	0.000154	0.000783	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ITGB3—coronary artery disease	0.000154	0.000783	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—LPL—coronary artery disease	0.000154	0.000781	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—LPL—coronary artery disease	0.000154	0.000781	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MEF2C—coronary artery disease	0.000153	0.000774	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MEF2C—coronary artery disease	0.000153	0.000774	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CD36—coronary artery disease	0.000152	0.00077	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CD36—coronary artery disease	0.000152	0.00077	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MMP9—coronary artery disease	0.000152	0.00077	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.000152	0.000769	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6R—coronary artery disease	0.000152	0.000769	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6R—coronary artery disease	0.000152	0.000769	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6R—coronary artery disease	0.000151	0.000766	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP2—coronary artery disease	0.00015	0.000761	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP2—coronary artery disease	0.00015	0.000761	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ITGB3—coronary artery disease	0.000149	0.000755	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ITGB3—coronary artery disease	0.000149	0.000755	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—JAK2—coronary artery disease	0.000149	0.000754	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—ITGB3—coronary artery disease	0.000147	0.000743	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CD36—coronary artery disease	0.000146	0.000742	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CD36—coronary artery disease	0.000146	0.000742	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ADIPOQ—coronary artery disease	0.000146	0.000741	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—LEP—coronary artery disease	0.000146	0.000739	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000146	0.000738	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000145	0.000736	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP2—coronary artery disease	0.000145	0.000734	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP2—coronary artery disease	0.000145	0.000734	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP2—coronary artery disease	0.000144	0.000731	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KDR—coronary artery disease	0.000143	0.000724	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—JAK2—coronary artery disease	0.000142	0.000721	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAPK14—coronary artery disease	0.000142	0.000719	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—LEP—coronary artery disease	0.000139	0.000707	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6ST—coronary artery disease	0.000137	0.000694	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—FGF2—coronary artery disease	0.000137	0.000694	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—JAK2—coronary artery disease	0.000137	0.000693	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—JAK2—coronary artery disease	0.000137	0.000693	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KDR—coronary artery disease	0.000137	0.000693	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—VEGFA—coronary artery disease	0.000136	0.000691	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAPK14—coronary artery disease	0.000136	0.000688	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—LEP—coronary artery disease	0.000134	0.000679	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—LEP—coronary artery disease	0.000134	0.000679	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ITGAV—coronary artery disease	0.000133	0.000674	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—JAK2—coronary artery disease	0.000132	0.000668	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—JAK2—coronary artery disease	0.000132	0.000668	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—JAK2—coronary artery disease	0.000131	0.000665	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KDR—coronary artery disease	0.000131	0.000665	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KDR—coronary artery disease	0.000131	0.000665	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6ST—coronary artery disease	0.000131	0.000664	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAPK14—coronary artery disease	0.00013	0.000661	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAPK14—coronary artery disease	0.00013	0.000661	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—LEP—coronary artery disease	0.000129	0.000655	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—LEP—coronary artery disease	0.000129	0.000655	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PPARG—coronary artery disease	0.000127	0.000644	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KDR—coronary artery disease	0.000127	0.000642	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KDR—coronary artery disease	0.000127	0.000642	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—GSK3B—coronary artery disease	0.000126	0.00064	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6ST—coronary artery disease	0.000126	0.000638	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6ST—coronary artery disease	0.000126	0.000638	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAPK14—coronary artery disease	0.000126	0.000637	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAPK14—coronary artery disease	0.000126	0.000637	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CREB1—coronary artery disease	0.000125	0.000635	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KDR—coronary artery disease	0.000125	0.000632	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	0.000123	0.000625	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP9—coronary artery disease	0.000123	0.000623	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MAPK1—coronary artery disease	0.000123	0.000622	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6R—coronary artery disease	0.000122	0.000619	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PPARG—coronary artery disease	0.000121	0.000616	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6ST—coronary artery disease	0.000121	0.000615	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6ST—coronary artery disease	0.000121	0.000615	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—GSK3B—coronary artery disease	0.000121	0.000612	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CREB1—coronary artery disease	0.00012	0.000607	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6ST—coronary artery disease	0.00012	0.000606	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARGC1A—coronary artery disease	0.000119	0.000603	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP9—coronary artery disease	0.000117	0.000595	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6R—coronary artery disease	0.000117	0.000592	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARG—coronary artery disease	0.000117	0.000592	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARG—coronary artery disease	0.000117	0.000592	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP2—coronary artery disease	0.000117	0.000591	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—GSK3B—coronary artery disease	0.000116	0.000588	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—GSK3B—coronary artery disease	0.000116	0.000588	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CREB1—coronary artery disease	0.000115	0.000583	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CREB1—coronary artery disease	0.000115	0.000583	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP9—coronary artery disease	0.000113	0.000572	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP9—coronary artery disease	0.000113	0.000572	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARG—coronary artery disease	0.000113	0.00057	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARG—coronary artery disease	0.000113	0.00057	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6R—coronary artery disease	0.000112	0.000569	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6R—coronary artery disease	0.000112	0.000569	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—GSK3B—coronary artery disease	0.000112	0.000567	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—GSK3B—coronary artery disease	0.000112	0.000567	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP2—coronary artery disease	0.000112	0.000565	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CREB1—coronary artery disease	0.000111	0.000563	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CREB1—coronary artery disease	0.000111	0.000563	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—FGF2—coronary artery disease	0.000111	0.000561	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—coronary artery disease	0.00011	0.000559	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—GSK3B—coronary artery disease	0.00011	0.000559	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—CREB1—coronary artery disease	0.000109	0.000554	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP9—coronary artery disease	0.000109	0.000552	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP9—coronary artery disease	0.000109	0.000552	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP9—coronary artery disease	0.000108	0.000549	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LPL—coronary artery disease	0.000108	0.000549	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6R—coronary artery disease	0.000108	0.000549	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6R—coronary artery disease	0.000108	0.000549	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MEF2C—coronary artery disease	0.000107	0.000544	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP2—coronary artery disease	0.000107	0.000543	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP2—coronary artery disease	0.000107	0.000543	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6R—coronary artery disease	0.000107	0.000541	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—JAK2—coronary artery disease	0.000106	0.000538	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—FGF2—coronary artery disease	0.000106	0.000537	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—coronary artery disease	0.000106	0.000536	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—coronary artery disease	0.000105	0.000535	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ITGB3—coronary artery disease	0.000105	0.00053	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP2—coronary artery disease	0.000103	0.000524	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP2—coronary artery disease	0.000103	0.000524	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CD36—coronary artery disease	0.000103	0.000522	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP2—coronary artery disease	0.000102	0.000516	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—FGF2—coronary artery disease	0.000102	0.000516	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—FGF2—coronary artery disease	0.000102	0.000516	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—JAK2—coronary artery disease	0.000102	0.000515	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—coronary artery disease	0.000101	0.000514	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—coronary artery disease	0.000101	0.000514	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MAPK1—coronary artery disease	9.93e-05	0.000503	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—FGF2—coronary artery disease	9.81e-05	0.000497	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—FGF2—coronary artery disease	9.81e-05	0.000497	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—coronary artery disease	9.77e-05	0.000495	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—coronary artery disease	9.77e-05	0.000495	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—JAK2—coronary artery disease	9.76e-05	0.000495	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—JAK2—coronary artery disease	9.76e-05	0.000495	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—coronary artery disease	9.73e-05	0.000493	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MAPK1—coronary artery disease	9.49e-05	0.000481	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—coronary artery disease	9.43e-05	0.000478	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—JAK2—coronary artery disease	9.41e-05	0.000477	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—JAK2—coronary artery disease	9.41e-05	0.000477	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—JAK2—coronary artery disease	9.27e-05	0.00047	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MAPK1—coronary artery disease	9.12e-05	0.000462	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MAPK1—coronary artery disease	9.12e-05	0.000462	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LEP—coronary artery disease	9.08e-05	0.00046	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TGFB1—coronary artery disease	8.93e-05	0.000453	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KDR—coronary artery disease	8.9e-05	0.000451	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAPK14—coronary artery disease	8.84e-05	0.000448	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MAPK1—coronary artery disease	8.8e-05	0.000446	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MAPK1—coronary artery disease	8.8e-05	0.000446	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP9—coronary artery disease	8.76e-05	0.000444	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MAPK1—coronary artery disease	8.76e-05	0.000444	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6ST—coronary artery disease	8.53e-05	0.000432	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—coronary artery disease	8.53e-05	0.000432	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP9—coronary artery disease	8.38e-05	0.000425	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TNF—coronary artery disease	8.34e-05	0.000423	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP9—coronary artery disease	8.05e-05	0.000408	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP9—coronary artery disease	8.05e-05	0.000408	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARG—coronary artery disease	7.91e-05	0.000401	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—coronary artery disease	7.87e-05	0.000399	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—GSK3B—coronary artery disease	7.87e-05	0.000399	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CREB1—coronary artery disease	7.8e-05	0.000396	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP9—coronary artery disease	7.77e-05	0.000394	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP9—coronary artery disease	7.77e-05	0.000394	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP9—coronary artery disease	7.65e-05	0.000388	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—coronary artery disease	7.63e-05	0.000387	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6R—coronary artery disease	7.61e-05	0.000386	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—coronary artery disease	7.53e-05	0.000382	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—coronary artery disease	7.29e-05	0.00037	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP2—coronary artery disease	7.26e-05	0.000368	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—coronary artery disease	7.23e-05	0.000367	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—coronary artery disease	7.23e-05	0.000367	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TGFB1—coronary artery disease	7.22e-05	0.000366	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAPK1—coronary artery disease	7.08e-05	0.000359	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—coronary artery disease	7.01e-05	0.000355	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—coronary artery disease	7.01e-05	0.000355	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—coronary artery disease	6.97e-05	0.000353	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—coronary artery disease	6.97e-05	0.000353	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TGFB1—coronary artery disease	6.91e-05	0.00035	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FGF2—coronary artery disease	6.9e-05	0.00035	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—coronary artery disease	6.87e-05	0.000348	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAPK1—coronary artery disease	6.77e-05	0.000343	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—coronary artery disease	6.76e-05	0.000343	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—coronary artery disease	6.76e-05	0.000343	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TNF—coronary artery disease	6.74e-05	0.000342	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—coronary artery disease	6.73e-05	0.000341	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TGFB1—coronary artery disease	6.64e-05	0.000336	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TGFB1—coronary artery disease	6.64e-05	0.000336	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—JAK2—coronary artery disease	6.61e-05	0.000335	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAPK1—coronary artery disease	6.51e-05	0.00033	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAPK1—coronary artery disease	6.51e-05	0.00033	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TNF—coronary artery disease	6.45e-05	0.000327	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TGFB1—coronary artery disease	6.4e-05	0.000324	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TGFB1—coronary artery disease	6.4e-05	0.000324	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAPK1—coronary artery disease	6.28e-05	0.000318	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAPK1—coronary artery disease	6.28e-05	0.000318	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT1—coronary artery disease	6.21e-05	0.000315	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TNF—coronary artery disease	6.2e-05	0.000314	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TNF—coronary artery disease	6.2e-05	0.000314	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAPK1—coronary artery disease	6.18e-05	0.000313	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TNF—coronary artery disease	5.98e-05	0.000303	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TNF—coronary artery disease	5.98e-05	0.000303	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP9—coronary artery disease	5.46e-05	0.000277	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—coronary artery disease	5.44e-05	0.000276	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—coronary artery disease	5.21e-05	0.000264	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT1—coronary artery disease	5.02e-05	0.000255	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—coronary artery disease	5e-05	0.000254	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—coronary artery disease	5e-05	0.000254	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—coronary artery disease	4.9e-05	0.000248	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—coronary artery disease	4.82e-05	0.000244	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—coronary artery disease	4.82e-05	0.000244	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT1—coronary artery disease	4.8e-05	0.000243	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—coronary artery disease	4.75e-05	0.000241	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT1—coronary artery disease	4.61e-05	0.000234	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT1—coronary artery disease	4.61e-05	0.000234	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TGFB1—coronary artery disease	4.5e-05	0.000228	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT1—coronary artery disease	4.45e-05	0.000226	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT1—coronary artery disease	4.45e-05	0.000226	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAPK1—coronary artery disease	4.41e-05	0.000224	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TNF—coronary artery disease	4.2e-05	0.000213	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—coronary artery disease	3.39e-05	0.000172	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT1—coronary artery disease	3.13e-05	0.000159	CbGpPWpGaD
